Skip to content

Biohaven BHVN Earnings yield

Earnings yield at other companies

Eli Lilly logo
Eli LillyLLY
3.1%+1.6pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-6.9%-1.6pp
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-7.2%-2.9pp
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-30.9%-10.6pp
uniQure logo
uniQureQURE
-20.4%-6.5pp
Roivant Sciences logo
Roivant SciencesROIV
-5.4%-5.8pp

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Calculated from Biohaven’s reported figures.

Based on trailing twelve months.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's earnings yield?
Biohaven (BHVN) reported earnings yield of -50.9% in Q1 2026.
How has Biohaven's earnings yield changed year-over-year?
Biohaven's earnings yield decreased by 40.5% year-over-year, from -36.2% to -50.9%.
What is the long-term trend for Biohaven's earnings yield?
Over 3 years (2022 to 2025), Biohaven's earnings yield has grown at a -6.5% compound annual growth rate (CAGR), from -60.3% to -49.3%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.